[Parvovirus B19 outbreak in a rural community in Alicante]. 2002

Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
Sección de Epidemiología. Centro Salud Pública de Alicante. España. francisco.martinezcapillo@sanidad.m400.gva.es

BACKGROUND Parvovirus B19 (PVB19) has been identified as the cause of erythema infectiosum. The epidemiology of PVB19 has not been extensively studied in Spain or in the autonomic community of Valencia. The aim of this work is to describe an outbreak of PVB19 infection occurring in the area of Monforte del Cid, Alicante. METHODS A probable case was defined as: all subjects living in Monforte who presented a rash (mainly facial) and/or arthralgia starting from November 1999. A confirmed case was defined as: a probable case confirmed by laboratory analysis or a case having an epidemiological link. Laboratory confirmation included specific IgG or IgM antibodies to PVB19. Cases were mainly detected through the Monforte del Cid Primary Health Care Center. RESULTS The outbreak occurred from November 1999 to August 2000. A total of 118 cases were detected, giving an overall attack rate (AR) of 23.2 cases per 1,000 inhabitants. The highest rates were in the age groups of 0-4 years old (AR 5 114.5 per 1,000) and 5-9 years old (AR 5 180.3 per 1,000). By gender, the AR per 1,000 inhabitants was 26.9 in men and 16.7 in women. Two of the cases were pregnant women and one of them had a miscarriage. CONCLUSIONS The outbreak of erythema infectiosum lasted 10 months and mainly affected children under 14 years old. Active surveillance was focussed on women in the first three months of pregnancy.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
December 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
January 2008, Enfermedades infecciosas y microbiologia clinica,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
February 1996, Archives of physical medicine and rehabilitation,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
December 1995, American journal of infection control,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
January 1992, Lancet (London, England),
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
December 1992, Communicable disease report. CDR weekly,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
November 2023, Viruses,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
October 1994, Epidemiology and infection,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
July 2000, The Journal of hospital infection,
Francisco Martínez-Campillo, and Josefa López, and Mercedes Verdú, and Mariano Andreu, and María Vicenta Rigo
February 2004, Journal of medical microbiology,
Copied contents to your clipboard!